CBDL .016 NEWS Significant Revenue Growth All Content

CBDL .016 NEWS Significant Revenue Growth


All Content and Data provided by Third-Parties — Terms of Use
CBD Life Sciences Subsidiary Continues Significant Revenue Growth
GLOBENEWSWIRE 8:00 AM ET 6/18/2019
Symbol Last Price Change
CBDL 0.016up 0 (0%)
QUOTES AS OF 03:22:31 PM ET 06/17/2019
SCOTTSDALE, ARIZONA, June 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc.(CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC), is continuing to experience significant revenue growth as a result of the expansion and market acceptance of its product lines.


LBC currently offers the following high-quality line of organic cannabidiol based supplements and wellness products:

- CBD Rich Hemp Oil Drops

- CBD Hemp Oil Anxiety & Sleep E Liquid

- CBD Vitamin B12 Drop

- CBD Biotin Drops

- CBD Garcinia Cambogia Drops

- CBD Terpenes & Tinctures

- CBD Gummy Bears

- CBD Pain Relief Cream

- CBD Freeze Pain Cold Rub Therapy

- CBD Pet Supplement Drops

- CBD Pet Treats

- Pain Cream for Pets

- CBD infused vape pens

- CBD based anti-aging skin product line

Not only is LBC seeing growth in retail sales but it is now being approached to provide ‘white label’ versions of its product lines.

“We are thrilled at how rapidly our products are being accepted and recognized in the marketplace. In the last few months we have added a full line of anti-aging products as well as a CBD vaping pen…and there is much more on the way!” exclaimed Lisa Nelson, President & CEO of CBD Life Science.

About CBD Life Sciences Inc.(CBDL)

CBD Life Sciences Inc. (CBDL) is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘CBDL’. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector.

About LBC Bioscience Inc.

LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc.(CBDL) LBC has developed and is retailing/wholesaling a full line of cannabidiol based organic products including: hemp drops, massage oils, pain relief creams, anxiety and sleep supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for your pets. LBC’s products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com.

Contact Information

Investor Relations

Ten Associates LLC

11529 N. 120th St.

Scottsdale, Arizona

85259 USA

Telephone: 480-326-8577

Contact: Thomas E. Nelson

Email: tenassociates33@gmail.com

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Optium Cyber Systems, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Image: CBD Final Logo.jpg


Source: CBD Life Sciences Inc.(CBDL)
2019 GlobeNewswire, Inc.



















CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL CBDL